CERo Therapeutics (CERO) Q4 2025 Earnings

19NovConfirmed
Q2 2025
Q3 2025
Q4 2025
-124.26
-83.09
-41.93
-0.76

Details

Expected EPS
-0.76
Actual EPS
-0.88
Surprise EPS
-0.12
Surprise Percent
+15.79%

Description

CERo Therapeutics (CERO) has reported earnings of -0.88 per share for Q4 2025.

0 Comments

Share your thoughts